European Academy of Allergy and Clinical Immunology
EAACI Congress 2025 - Breaking Boundaries in Allergy, Asthma, and Clinical Immunology: Integrating Planetary Health for a Sustainable Future
EAACI Congress 2025 - Breaking Boundaries in Allergy, Asthma, and Clinical Immunology: Integrating Planetary Health for a Sustainable Future
ZURICH, March 18, 2025 (GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical Immunology (EAACI) proudly presents the EAACI Congress 2025, set to take place June 13-16 in Glasgow, United Kingdom. This year’s theme, “Breaking Boundaries in Allergy, Asthma, and Clinical Immunology: Integrating Planetary Health for a Sustainable Future,” highlights the critical link between environmental changes and allergic diseases.
Scientific Excellence & Global Collaboration
Bringing together leading experts from across the world, EAACI Congress 2025 is the premier event for networking and collaboration in allergy and immunology. Delegates can expect cutting-edge research presentations, interactive sessions, and invaluable opportunities to connect with peers shaping the future of the field. Visit the scientific programme to learn more.
Premier Venue & Registration Details
The congress will be hosted at the Scottish Event Campus (SEC), the UK’s largest integrated conference and exhibition centre. Located in the heart of Glasgow, SEC offers state-of-the-art facilities and an engaging atmosphere for scientific exchange.
Glasgow, a vibrant city on the banks of the River Clyde, is known for its striking architecture, contemporary art scene, and renowned music venues, providing the perfect setting for this landmark event.
Standard registration fees are available until April 18th, with tailored rates for EAACI members, non-members, seniors, juniors, students, nurses, and lab technicians—ensuring accessibility for all professionals in the field.
Industry Activities & Exhibition
The EAACI Congress 2025 offers an exclusive platform for industry leaders to showcase innovations in allergy and immunology. The exhibition area will feature cutting-edge products and therapies, fostering interaction between delegates and industry partners through dynamic presentations and engaging activities.
Special Highlight: Allergy Run 2025
An exciting feature of the congress is the Allergy Run 2025, a community event promoting awareness of allergy, asthma, and immunology while encouraging a healthy lifestyle. Stay tuned for details on how to participate!
Registration & More Information
Visit the EAACI Congress 2025 website to explore the full program and secure your spot. Follow EAACI on social media for the latest updates.
About EAACI
The European Academy of Allergy and Clinical Immunology (EAACI) is the leading professional organization dedicated to excellence in allergy and immunology. Learn more at https://eaaci.org.
Contact: communications@eaaci.org
+41 44 205 55 33
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/26f65a77-9d14-450a-ae0f-52c3f689ffb4

Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S12.5.2025 08:01:21 CEST | Press release
Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) is an efficacious and well-tolerated long-acting growth hormone in children with growth disorders: results from REAL8 phase 3 basket study presented at the joint Congress of ESPE and ESE
Aspo Plc12.5.2025 08:00:00 CEST | Press release
Aspo Plc’s Interim Report, January 1 – March 31, 2025: Strong start for year 2025 with continued profitability improvement
KBC Groep12.5.2025 08:00:00 CEST | Press release
KBC Group: Regulated information – 12 May 2025 before trading hours (08h00)
Norsk Hydro12.5.2025 08:00:00 CEST | Press release
Norsk Hydro: Ex-dividend NOK 2.25 today
Trifork Group AG12.5.2025 07:30:26 CEST | Press release
27/2025・Trifork Group: Weekly report on share buyback
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom